We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Endometrial Sampling (Pipelle)in IVF Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2006 by Sheba Medical Center.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00411021
First Posted: December 13, 2006
Last Update Posted: December 13, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Sheba Medical Center
December 12, 2006
December 13, 2006
December 13, 2006
Not Provided
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Endometrial Sampling (Pipelle)in IVF Patients
Endometrial Sampling (Pipelle)in IVF Patients
A prospective cross-over randomized study aimed to test the hypothesis that local injury of the endometrium increases the implantation rate in the successive cycle. Seventy IVF patients will be randomly selected to undergo either endometrial biopsies or minimal cervical scratch on days 8-10 and 21-23 of their cycle, preceding the IVF treatment. If not pregnant, the women will continue for another IVF cycle, preceded by endometrial or cervical scratch complimentary to their procedure in the first cycle. The main major outcomes will include pregnancy rate, implantation rate, endometrial thickness, abortion rate, live births and embryo quality.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single
Primary Purpose: Treatment
Infertility
Procedure: Pipelle (Endometrial Sampling)
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
70
Not Provided
Not Provided

Inclusion Criteria:

  • Women undergoing IVF treatment
  • Repeated Implantation failure

Exclusion Criteria:

  • PID or suspected PID
  • Undiagnosed Irregular Bleeding
Sexes Eligible for Study: Female
20 Years to 45 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Israel
 
 
NCT00411021
SHEBA-05-3674-MB-CTIL
Not Provided
Not Provided
Not Provided
Not Provided
Sheba Medical Center
Not Provided
Principal Investigator: Micha Baum, MD Sheba Medical Center, Israel
Sheba Medical Center
December 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP